VAERS reports by lot

GSK DTaP/Tdap lot TD2FD: VAERS reports

20 VAERS reports list lot TD2FD as a GSK DTaP/Tdap vaccine, received between 2024-04-25 and 2026-04-17. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1027%
Musculoskeletal719%
Neurological616%
General / Systemic (non-local)411%
Cardiac / Cardiovascular38%
Allergic / Anaphylactic25%
Gastrointestinal25%
Dermatological (non-injection-site)25%
Respiratory13%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Washington2
California2
Tennessee2
Michigan2
South Dakota2
Ohio1
Texas1
Arizona1
Wyoming1
Pennsylvania1
Georgia1
Missouri1

Reports by month received

MonthReportsBar
2024-042
2024-052
2024-064
2024-074
2024-081
2024-093
2024-101
2025-111
2026-011
2026-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): T325H · T343J · T7E4A · TF422 · TX77L · X357E

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.